Aflibercept for choroidal neovascularizations secondary to pseudoxanthoma elasticum: a prospective study.
Martin GliemJohannes BirtelPhilipp HerrmannRolf FimmersMoritz BergerChristoph CochAlmut WingenFrank G HolzPeter Charbel IssaPublished in: Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie (2019)
The results of this study indicate that intravitreal aflibercept is a treatment option for CNV secondary to PXE.